However, research does not currently support the claim that vitamin B12 reduces this risk
Summary: Vitamin B12 toxicity from supplementation is extremely rare, but persistently elevated serum levels may indicate underlying liver disease, kidney dysfunction, or haematological disorders requiring medical investigation
Inhibitor experiments: If an inhibitor lowers a response, the blocked pathway may be involved
Since several studies document a decrease in adherence as therapeutic complexity increases, an improvement in therapeutic adherence can be expected with the use of this drug, especially considering the excellent results that patients can achieve in terms of weight reduction
When given subcutaneously, the product is well-tolerated and non-irritant
Larger jumps risk triggering intolerance that wouldn't occur with gradual progression